Company Filing History:
Years Active: 2011
Title: The Innovations of Andrew Douglas McLeod
Introduction
Andrew Douglas McLeod is a notable inventor based in Auckland, New Zealand. He has made significant contributions to the field of pharmaceuticals, particularly with his work on clozapine formulations. His innovative approach has led to the development of a stable clozapine suspension formulation, which is crucial for patients requiring this medication.
Latest Patents
Andrew holds 1 patent for his invention titled "Stable clozapine suspension formulation." This patent describes a physicochemically stable aqueous composition that includes a clozapine suspension, enhancing the efficacy and safety of the medication for users.
Career Highlights
Andrew is currently employed at Douglas Pharmaceuticals Limited, where he continues to work on innovative pharmaceutical solutions. His expertise in formulation chemistry has positioned him as a valuable asset to the company and the industry at large.
Collaborations
Andrew has collaborated with notable colleagues such as Peter William Surman and Sharon Ferguson. Their combined efforts have contributed to advancements in pharmaceutical formulations and patient care.
Conclusion
Andrew Douglas McLeod's contributions to the field of pharmaceuticals through his innovative patent work exemplify the impact of dedicated inventors in improving healthcare solutions. His ongoing work at Douglas Pharmaceuticals Limited continues to pave the way for future advancements in medication formulations.